Back to search

Article

Whole genome methylation sequencing in blood from persons with mild cognitive impairment and dementia due to Alzheimer’s disease identifies cognitive status

2024-09-27

Abstract excerpt

<h4>INTRODUCTION</h4> Whole genome methylation sequencing (WGMS) in blood identifies differential DNA methylation in persons with late-onset dementia due to Alzheimer’s disease (AD) but has not been tested in persons with mild cognitive impairment (MCI). <h4>METHODS</h4> We used WGMS to compare DNA methylation levels at 25,244,219 CpG loci in 382 blood samples from 99 persons with MCI, 109 with AD, and 174 who a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eecc0c87-6731-541c-81b4-5a54ac4e4294
DOI
10.1101/2024.09.26.615196
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Whole genome methylation sequencing in blood from persons with mild cognitive impairment and dementia due to Alzheimer’s disease identifies cognitive statusDOI 10.1101/2024.09.26.615196
Select a neighboring publication to make it the new centre.